News on Profile Therapeutics plc from BioPortfolio.com http://www.BioPortfolio.com Consolidated Profile Therapeutics plc news from BioPortfolio.com Tue, 09 Feb 2010 21:06:17 GMT en Biotech Stocks: Drug stocks gain; Cell Therapeutics reboundshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036012&HITNO=0&MSIZE=246&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Profile%20Therapeutics%20plc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036012&THISHREF=http://c.moreover.com/click/here.pl%3fz2536463997%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036012&HITNO=0&MSIZE=246&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Profile%20Therapeutics%20plc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036012&THISHREF=http://c.moreover.com/click/here.pl%3fz2536463997%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMarketWatch: Drug stocks gain; Cell Therapeutics reboundshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035768&HITNO=1&MSIZE=246&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Profile%20Therapeutics%20plc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035768&THISHREF=http://c.moreover.com/click/here.pl%3fz2536363185%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035768&HITNO=1&MSIZE=246&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Profile%20Therapeutics%20plc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035768&THISHREF=http://c.moreover.com/click/here.pl%3fz2536363185%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMarketWatch: Silence Therapeutics gets notice of allowance for RNA Interference patenthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033873&HITNO=2&MSIZE=246&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Profile%20Therapeutics%20plc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033873&THISHREF=http://c.moreover.com/click/here.pl%3fz2535463516%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033873&HITNO=2&MSIZE=246&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Profile%20Therapeutics%20plc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033873&THISHREF=http://c.moreover.com/click/here.pl%3fz2535463516%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: UPDATE 3-Cell Therapeutics drug draws US FDA staff concernshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030552&HITNO=3&MSIZE=246&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Profile%20Therapeutics%20plc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030552&THISHREF=http://c.moreover.com/click/here.pl%3fz2533680824%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030552&HITNO=3&MSIZE=246&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Profile%20Therapeutics%20plc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030552&THISHREF=http://c.moreover.com/click/here.pl%3fz2533680824%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comReuters India: Silence Therapeutics Receives Notice of Allowance for RNA Interference (RNAi) Patent Covering Novel Cancer Targethttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4027728&HITNO=4&MSIZE=246&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Profile%20Therapeutics%20plc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4027728&THISHREF=http://c.moreover.com/click/here.pl%3fz2532315799%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4027728&HITNO=4&MSIZE=246&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Profile%20Therapeutics%20plc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4027728&THISHREF=http://c.moreover.com/click/here.pl%3fz2532315799%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFreshnews.com: Silence Therapeutics Receives Notice of Allowance for RNA Interference (RNAi) Patent Covering Novel Cancer Tarhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4027756&HITNO=5&MSIZE=246&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Profile%20Therapeutics%20plc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4027756&THISHREF=http://c.moreover.com/click/here.pl%3fz2532326413%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4027756&HITNO=5&MSIZE=246&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Profile%20Therapeutics%20plc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4027756&THISHREF=http://c.moreover.com/click/here.pl%3fz2532326413%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBreitbart.com: Silence Therapeutics Receives Notice of Allowance for RNA Interference (RNAi) Patent Covering Novel Cancer Tarhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4027660&HITNO=6&MSIZE=246&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Profile%20Therapeutics%20plc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4027660&THISHREF=http://c.moreover.com/click/here.pl%3fz2532284121%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4027660&HITNO=6&MSIZE=246&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Profile%20Therapeutics%20plc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4027660&THISHREF=http://c.moreover.com/click/here.pl%3fz2532284121%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Finance: Silence Therapeutics Receives Notice of Allowance for RNA Interference (RNAi) Patent Covering Novel Cancer Tarhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4027533&HITNO=7&MSIZE=246&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Profile%20Therapeutics%20plc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4027533&THISHREF=http://c.moreover.com/click/here.pl%3fz2532235850%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4027533&HITNO=7&MSIZE=246&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Profile%20Therapeutics%20plc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4027533&THISHREF=http://c.moreover.com/click/here.pl%3fz2532235850%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR Newswire via Yahoo!: Silence Therapeutics plc awarded notice of allowance for RNAi patent targeting cancerhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030235&HITNO=8&MSIZE=246&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Profile%20Therapeutics%20plc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030235&THISHREF=http://c.moreover.com/click/here.pl%3fz2533513559%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030235&HITNO=8&MSIZE=246&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Profile%20Therapeutics%20plc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030235&THISHREF=http://c.moreover.com/click/here.pl%3fz2533513559%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comIndividual.com: Silence Gets Notice of Allowance for Key RNAi Patenthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030936&HITNO=9&MSIZE=246&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Profile%20Therapeutics%20plc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030936&THISHREF=http://c.moreover.com/click/here.pl%3fz2533901587%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030936&HITNO=9&MSIZE=246&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Profile%20Therapeutics%20plc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030936&THISHREF=http://c.moreover.com/click/here.pl%3fz2533901587%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Silence Therapeutics Receives Notice of Allowance for RNA Interference (RNAi) Patent Covering Novel Cancer Tarhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030737&HITNO=10&MSIZE=246&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Profile%20Therapeutics%20plc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030737&THISHREF=http://c.moreover.com/click/here.pl%3fz2533801892%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030737&HITNO=10&MSIZE=246&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Profile%20Therapeutics%20plc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030737&THISHREF=http://c.moreover.com/click/here.pl%3fz2533801892%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: Silence Therapeutics Receives Notice of Allowance for RNA Interference (RNAi) Patent Covering Novel Cancer Tarhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029220&HITNO=11&MSIZE=246&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Profile%20Therapeutics%20plc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029220&THISHREF=http://c.moreover.com/click/here.pl%3fz2533035539%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029220&HITNO=11&MSIZE=246&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Profile%20Therapeutics%20plc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029220&THISHREF=http://c.moreover.com/click/here.pl%3fz2533035539%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Silence Therapeutics plc awarded notice of allowance for RNAi patent targeting cancerhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028993&HITNO=12&MSIZE=246&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Profile%20Therapeutics%20plc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028993&THISHREF=http://c.moreover.com/click/here.pl%3fz2532942795%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028993&HITNO=12&MSIZE=246&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Profile%20Therapeutics%20plc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028993&THISHREF=http://c.moreover.com/click/here.pl%3fz2532942795%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTradingMarkets: Silence Therapeutics Receives Notice of Allowance for RNA Interference (RNAi) Patent Covering Novel Cancer Targethttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028701&HITNO=13&MSIZE=246&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Profile%20Therapeutics%20plc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028701&THISHREF=http://c.moreover.com/click/here.pl%3fz2532826318%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028701&HITNO=13&MSIZE=246&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Profile%20Therapeutics%20plc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028701&THISHREF=http://c.moreover.com/click/here.pl%3fz2532826318%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comAtlanta Business Chronicle: Silence Therapeutics Receives Notice of Allowance for RNA Interference (RNAi) Patent Covering Novel Cancer Tarhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028626&HITNO=14&MSIZE=246&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Profile%20Therapeutics%20plc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028626&THISHREF=http://c.moreover.com/click/here.pl%3fz2532789179%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028626&HITNO=14&MSIZE=246&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Profile%20Therapeutics%20plc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028626&THISHREF=http://c.moreover.com/click/here.pl%3fz2532789179%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: